IAG Wealth Partners’s Quest Diagnostics DGX Stock Holding History

IAG Wealth Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$848	Hold	4	–	–	﹤0.01%	489
2026 Q1	$784	Hold	4	–	–	﹤0.01%	490
2025 Q4	$694	Hold	4	–	–	﹤0.01%	475
2025 Q3	$762	Hold	4	–	–	﹤0.01%	490
2025 Q2	$719	Hold	4	–	–	﹤0.01%	465
2025 Q1	$677	Hold	4	–	–	﹤0.01%	478
2024 Q4	$603	Hold	4	–	–	﹤0.01%	490
2024 Q3	$621	Buy	+4	New	+$597	﹤0.01%	473

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

IAG Wealth Partners's DGX Position: Q2 2026 in Review

IAG Wealth Partners held its Quest Diagnostics (DGX) position steady in Q2 2026 at 4 shares worth $848. The position accounts for ﹤0.01% of the portfolio, ranked #489.

IAG Wealth Partners first reported a position in DGX in Q3 2024 and has held it in 8 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

IAG Wealth Partners held 4 shares of Quest Diagnostics worth $848 as of Q2 2026.
IAG Wealth Partners left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of IAG Wealth Partners's portfolio in Q2 2026, its #489 holding.
IAG Wealth Partners first reported a position in Quest Diagnostics in Q3 2024 and has held it in 8 quarters since.
1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on IAG Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.